Methodist Health System
174
30
39
87
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.9%
19 terminated/withdrawn out of 174 trials
82.1%
-4.5% vs industry average
2%
4 trials in Phase 3/4
0%
0 of 87 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (174)
To Evaluate the Impact of MRSA Nasal Screen Implementation.
Role: lead
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
Role: lead
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
Role: lead
Acute Subdural Hematoma
Role: lead
Cardiac Clearance vs G60 Hip Frailty Index
Role: lead
Traumatic Cardiac Arrest
Role: lead
Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool
Role: lead
Analysis of Cardiac Biomarker Racial Discrepancies
Role: lead
Blunt Traumatic Aortic Injury
Role: lead
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients
Role: lead
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose Challenge
Role: lead
Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
Role: lead
Outcomes Using MARS for Patients With ALF
Role: lead
Pre-hospital Tourniquet in Extremity Injury
Role: lead
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Role: lead
Antibiotic Use in Facial Fracture Post Injury
Role: lead
The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates
Role: lead
Resuscitative Thoracotomy Practices
Role: lead
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
Role: lead
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
Role: lead